Work

P1.17.57 Estimates of Clinical Endpoints in Matched Patients Between the French Cancer Cohort (FCC) and Durvalumab Stage III NSCLC Eap

Year: 2025

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2025.09.442

Authors: I. Charkaoui, M. Narbeburu, M. Licour, V-P. Luu, C. Morgand, C. Le Bihan, N. Ozan

Institutions: Institut National du Cancer, AstraZeneca (France)

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4415520552

FWCI:

Cites:

Cited by:

Related to: 10